Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP14 regulates heme metabolism and ovarian cancer invasion through BACH1 deubiquitination and stabilization. | Biochem Biophys Res Commun | 2023 | 37229827 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases. | MedComm (2020) | 2023 | 37229485 | PubTator, text mining | PubMed |
| Pathophysiological role of BACH transcription factors in digestive system diseases. | Front Physiol | 2023 | 37228820 | PubTator, text mining | PubMed |
| AKT activation because of PTEN loss upregulates xCT via GSK3β/NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells. | Cell Rep | 2023 | 37210723 | PubTator, text mining | PubMed |
| Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications. | Explor Target Antitumor Ther | 2023 | 37205308 | PubTator, text mining | PubMed |
| Non-coding RNAs in breast cancer: with a focus on glucose metabolism reprogramming. | Discov Oncol | 2023 | 37204526 | PubTator, text mining | PubMed |
| ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patients. | Cell Death Dis | 2023 | 37198153 | PubTator, text mining | PubMed |
| Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy. | J Thorac Dis | 2023 | 37197539 | PubTator, text mining | PubMed |
| Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines. | Biomedicines | 2023 | 37189628 | PubTator, text mining | PubMed |
| A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity. | Cell Rep | 2023 | 37155329 | PubTator, text mining | PubMed |
| Insights into the Oncogenic, Prognostic, and Immunological Role of BRIP1 in Pan-Cancer: A Comprehensive Data-Mining-Based Study. | J Oncol | 2023 | 37153833 | PubTator, text mining | PubMed |
| Diversity and heterogeneity in human breast cancer adipose tissue revealed at single-nucleus resolution. | Front Immunol | 2023 | 37153595 | PubTator, text mining | PubMed |
| Identification and analysis of hub genes of hypoxia-immunity in type 2 diabetes mellitus. | Front Genet | 2023 | 37153000 | PubTator, text mining | PubMed |
| Disruption of the tumor suppressor-like activity of aryl hydrocarbon receptor by arsenic in epithelial cells and human lung cancer. | Int J Biol Sci | 2023 | 37151890 | PubTator, text mining | PubMed |
| Protein adducts with lipid peroxidation products in patients with psoriasis. | Redox Biol | 2023 | 37150149 | PubTator, text mining | PubMed |
| The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease. | Front Med (Lausanne) | 2023 | 37144034 | PubTator, text mining | PubMed |
| Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. | Front Oncol | 2023 | 37124518 | PubTator, text mining | PubMed |
| Identification of key ferroptosis-related biomarkers in steroid-induced osteonecrosis of the femoral head based on machine learning. | J Orthop Surg Res | 2023 | 37120553 | PubTator, text mining | PubMed |
| Redox and metal profiles in human coronary endothelial and smooth muscle cells under hyperoxia, physiological normoxia and hypoxia: Effects of NRF2 signaling on intracellular zinc. | Redox Biol | 2023 | 37116256 | PubTator, text mining | PubMed |
| α-Synuclein Attenuates Maneb Neurotoxicity through the Modulation of Redox-Sensitive Transcription Factors. | Oxid Med Cell Longev | 2023 | 37113744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=22